INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Navigating The Early Oncology Landscape: Market Trends And Insights
Explore the evolving landscape of early-phase oncology clinical trials, including strategic insights to empower operations teams in optimizing study design, site selection, and recruitment.
-
Rapid Results In A High-Stakes Dry Eye Disease Trial
This time-sensitive Phase 3 trial in dry eye disease required precision project management leveraging strong site relationships, ophthalmology-specific expertise, and data-driven site selection.
-
Enhancing Participant Payments: A New Approach
Managing participant payments in clinical trials is a multifaceted challenge impacting participants, sites, and sponsors alike. Delve into the intricacies and numerous hurdles faced in this process.
-
Harnessing The Potential Of Patient-Level Data In Clinical Trials
Join our panel of industry leaders as they explore innovative methods and best practices for incorporating fully consented patient data in clinical trials.
-
Spotlight On India: Regulatory Enhancements, Modernization, And Robust Data Collection7/25/2024
Explore India's adoption of global best practices, 24/7 work cycles, and audit readiness to ensure high standards of Good Clinical Practice, attract more trials, and provide robust data to stakeholders.
-
A Turnkey Solution For Clinical Trials In Australia6/16/2025
This presentation is centered on Australia's unique value proposition in the global research landscape, emphasizing its ability to deliver high-quality trials with speed and efficiency.
-
Adaptive Clinical Trials8/20/2024
An adaptive study design can be especially useful if there are uncertainties specific to your drug. Adjusting your study as data accumulates means getting answers sooner.
-
How Sponsors Can Leverage New Technologies To Lower Trial Costs1/6/2025
This study introduces sponsors to an innovative, lean, and efficient approach to data management that integrates site-facing technologies to streamline trial operations.
-
Improving ISR Success Rates In Bioanalysis Of Small Molecule Drugs1/23/2025
Leveraging incurred sample reanalysis (ISR) in your quality control helps your team mitigate risks, establish regulatory compliance, and instill confidence in your pharmacokinetic modeling.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
With effective IVD regulatory consulting from an expert team, sponsors can transform challenges into competitive advantages and bring high-quality diagnostics to market more efficiently.
-
Avance Clinical has located its Asia hub operations in Seoul, South Korea which is highly regarded for its advanced technology and scientific and medical excellence.
-
Inflammation is a primary pathogenic process in a wide range of diseases, including rheumatoid arthritis, cardiovascular disease, oncology and neuropsychiatric disorders.
-
Many biotechnology companies look at the Asia-Pacific region for their trials in Infectious diseases and Vaccines due to the high prevalence of diseases such as Hepatitis (Hepatitis B, Hepatitis C), HIV, and Influenza across the region.
-
Whether you need isotopically labelled (14C/SIL) compounds for nonclinical or clinical metabolism studies and the quantification of materials in biological matrices, our expertise provides the necessary labelled materials tailored to support your studies.